Description: IRESSA for advanced non-small cell lung cancer treatment with an EGFR-TK (epidermal growth factor receptor-tyrosine kinase) inhibitor. Site provides relevant lung cancer information for oncology research to health care professionals and patients.
Approx. monthly SE traffic: N/A
Approx. monthly SE traffic cost equivalent: N/A